Securing funding is a crucial step for any entrepreneurial venture, and Ginkgo Bioworks has been remarkably successful in this regard. The company has raised substantial amounts from both venture capital firms and government grants. Notable investors include Y Combinator, General Atlantic, and Viking Global Investors. In 2021, Ginkgo went public through a SPAC (Special Purpose Acquisition Company) merger, further boosting its financial resources to continue its innovative work.